Genprex (GNPX) Notes Payables (2017 - 2018)

Genprex (GNPX) posted quarterly Notes Payables of $279288.0 for Q1 2018, up 38.34% quarter-over-quarter from $201890.0 in Q4 2017.

Genprex (GNPX) Notes Payables (2017 - 2018) Analysis & Trends

Genprex's Notes Payables history runs 2 years deep, the most recent figure standing at $279288.0 for Q1 2018.

In Q1 2018, Notes Payables changed N/A year-over-year to $279288.0; the TTM figure through Mar 2018 stood at $279288.0 (changed N/A YoY), while the FY2017 annual figure was $201890.0, changed N/A from the prior year.
Notes Payables for Q1 2018 stood at $279288.0, up from $201890.0 in the prior quarter.
The five-year high for Notes Payables was $279288.0 in Q1 2018, with the low at $201890.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.41 Bn	131.56 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.14 Bn	78.15 Bn	3.93 Bn
3	Argenx Se	65.52 Bn	60.34 Bn	1.37 Bn
4	Moderna	58.21 Bn	53.07 Bn	52.00 Mn
5	BeOne Medicines	42.15 Bn	37.05 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn
7	BioNTech SE	27.95 Bn	9.56 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.30 Bn	26.46 Bn	-
10	Genprex	1.94 Mn	-13.22 Mn	-

Download Data

Date	Value
Mar 31, 2018	279,288.00
Dec 31, 2017	201,890.00